Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Translating p53-based therapies for cancer into the clinic
Sylvain Peuget, Xiaolei Zhou, Galina Selivanova
Nature reviews. Cancer (2024) Vol. 24, Iss. 3, pp. 192-215
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 50
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 20
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Salvia coccinea Buc'hoz ex Etl. Leaf extract mediated synthesis of zinc oxide nanoparticles: Assessment of antimicrobial, antioxidant and anticancer activity
Dharmalingam Kirubakaran, Kuppusamy Selvam, Govindaraj Bagyalakshmi, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105662-105662
Closed Access | Times Cited: 8
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 8
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
TP53 mutations and MDM2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds
Rituraj Chakraborty, Anupam Dutta, Rupak Mukhopadhyay
Clinical & Translational Oncology (2025)
Closed Access
Orphan nuclear receptor NR2E3 is a new molecular vulnerability in solid tumors by activating p53
Yidan Wang, Todd G. Kroll, Linhui Hao, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Secernin‐2 Stabilizes Histone Methyltransferase KMT2C to Suppress Progression and Confer Therapeutic Sensitivity to PARP Inhibition in Triple‐Negative Breast Cancer
Min‐Ying Huang, Jianhui Cai, Shao‐Ying Yang, et al.
Advanced Science (2025)
Open Access
Ribosomal protein L6 suppresses hepatocellular carcinoma by modulating FBXO22-mediated p53 degradation
Zhen Lei, Yiming Luo, Qinggang Fu, et al.
Cellular Signalling (2025) Vol. 127, pp. 111612-111612
Open Access
TP53 Mutations and PD-L1 Amplification in Vulvar Adenocarcinoma of the Intestinal Type: Insights From Whole Exome Sequencing of 2 Cases
Erisa Fujii, Mayumi Kobayashi Kato, Hanako Ono, et al.
International Journal of Gynecological Pathology (2025)
Closed Access
Glutathione reductase underlies the stability of mutant p53 by antagonizing protein glutathionylation
Liansheng Wang, Suqin Zhong, Xiaolin Fan, et al.
Redox Biology (2025), pp. 103522-103522
Open Access
Natural compound PEITC inhibits gain of function of p53 mutants in cancer cells by switching YAP-binding partners between p53 and p73
Yixuan Wang, Liwei Wang, Ying Huang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Chromatin Immunoprecipitation Reveals p53 Binding to G-Quadruplex DNA Sequences in Myeloid Leukemia Cell Lines
Libuše Kratochvilová, Alessandra Dinová, Natália Valková, et al.
ACS Bio & Med Chem Au (2025)
Open Access
TP53 Deficiency in the Natural History of Prostate Cancer
Heidemarie Ofner, Gero Kramer, Shahrokh F. Shariat, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 645-645
Open Access
An epigenetic regulator synergizes with alphavirus-mediated gene therapy via biomimetic delivery for enhanced cancer therapy
Yuqiong Xia, Maozhi Su, Zixuan Ye, et al.
Trends in biotechnology (2025)
Closed Access
Chromatin structure and gene transcription of recombinant p53 adenovirus vector within host
Duo Ning, Yuqing Deng, Simon Zhongyuan Tian
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Identifying KDM5B as the synthetic lethal target of KMT2D-mutated osteosarcoma
Liyu Yang, Jing Zhang, Yiting Jiang, et al.
Chemico-Biological Interactions (2025) Vol. 412, pp. 111451-111451
Closed Access
Exposure‐tumour growth inhibition modelling of brigimadlin using phase I solid tumour data to support phase II dose selection
Ida Neldemo, Kamunkhwala Gausi, Céline Sarr, et al.
British Journal of Clinical Pharmacology (2025)
Closed Access
Prunin: An Emerging Anticancer Flavonoid
Juie Nahushkumar Rana, Sohail Mumtaz
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2678-2678
Open Access
Extracorporeal shock waves effectively suppress colorectal cancer proliferation and growth
Xiaoli Zhang, Chun Ran, Qingzhi Song, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells
Iacopo Gesmundo, Francesca Pedrolli, F.R. Giglioli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3267-3267
Open Access
CircTADA2A stabilizes p53 via interacting with TRIM28 and suppresses the maintenance of FLT3-ITD acute myeloid leukemia
Ran Li, Xiaolu Wu, Kai Xue, et al.
Leukemia (2025)
Closed Access
Exploring the anti-colon cancer potential of febuxostat-based mixed metal complexes with 2,2′-bipyridine: MTT assay, toxicity evaluation, prediction profiles, and computational studies
Leila M. Abbass, Mustapha Belaidi, Saleh M. Bufarwa, et al.
Inorganic Chemistry Communications (2025), pp. 114460-114460
Closed Access
p53 transcriptionally activates DCP1B to suppress tumor progression and enhance tumor sensitivity to PI3K blockade in non-small cell lung cancer
Shiqi Chen, Qian Hao, Yu Gan, et al.
Cell Death and Differentiation (2025)
Open Access
Page 1 - Next Page

Scroll to top